CEPHEID (CPHD)
CEPHEID Beneish M-Score: -2.84
View CPHD Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CPHD Beneish M-Score Rankings
| Overall | 67th percentile | 1226 of 3761 |
| Sector | 73rd percentile | 210 of 781 in Technology |
| Industry | 75th percentile | 13 of 54 in Scientific & Technical Instruments |
CPHD Beneish M-Score Range, Past 5 Years
| Minimum | -3.230 | Dec 2009 |
| Maximum | -2.076 | Dec 2007 |
| Average | -2.862 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these CPHD related companies
CPHD News
$CPHD Target $50 based on new results Artcile link http://stks.co/3yVV May 24
about 4 days ago by Jack25bc
about 4 days ago by Jack25bc
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Rolling Out Another Assay
May 24, 8:45AM Street Insider
May 24, 8:45AM Street Insider
$CPHD a new lows, but volume lower than last week, and probably sellers fading away, a possible entry if it holds 52.88 area.
about 7 days ago by woowtrading
about 7 days ago by woowtrading
UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic Inflection
May 15, 11:04AM Benzinga
May 15, 11:04AM Benzinga
UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; Valuation Full
May 14, 11:29AM Benzinga
May 14, 11:29AM Benzinga
GARP Research Downgrades Cepheid (CPHD) to Neutral; Walking A Thin Line
May 14, 10:08AM Street Insider
May 14, 10:08AM Street Insider
Listen to $CPHD Cepheid at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3k3V
about 19 days ago by earningscast
about 19 days ago by earningscast
$CPHD http://stks.co/3aR0 If it breaks todays lod tomorrow.... will short it.
about 28 days ago by Bav111
about 28 days ago by Bav111
GARP Research Of In Defense on Cepheid (CPHD); Franchise Remains Solid Plus Progress In Pipeline
Apr 25, 12:57PM Street Insider
Apr 25, 12:57PM Street Insider
UBS Maintains a 'Neutral' on Cepheid (CPHD); Solid Top-Line Eclipsed by Below-Consensus EPS
Apr 20, 12:56PM Street Insider
Apr 20, 12:56PM Street Insider
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Pick Up Shares on Weakness
Apr 20, 8:51AM Street Insider
Apr 20, 8:51AM Street Insider
$CPHD's John Bishop wins the no-spin award for the week. Described this quarter's bottom line as "less than satisfactory to say the least."
about 38 days ago by bradloncar
about 38 days ago by bradloncar
News related to $CPHD: 'Cepheid cuts annual outlook after taking 1Q loss' http://stks.co/3QPR
about 39 days ago by TradeBot
about 39 days ago by TradeBot
Listen to $CPHD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3QMv
about 39 days ago by earningscast
about 39 days ago by earningscast
Cepheid, Inc. (CPHD) Reports In-Line Q1 Loss; Guides FY12 EPS Above Views
Apr 19, 4:08PM Street Insider
Apr 19, 4:08PM Street Insider
Canaccord Genuity on Life Sciences/Biomedical Devices & Services: Pipelines To Lead Way Through Q1
Apr 18, 10:25AM Street Insider
Apr 18, 10:25AM Street Insider
News related to $CPHD: 'Quidel rises on new clearance for flu test' http://stks.co/31m2
about 67 days ago by TradeBot
about 67 days ago by TradeBot
Approaching a pivot after a few week of earnings breakout consolidation $CPHD http://chart.ly/rflpbdb
about 70 days ago by ivanhoff
about 70 days ago by ivanhoff
$CPHD http://stks.co/2uxy flagging with a trigger long over 43 to a MM at 47
about 72 days ago by harmongreg
about 72 days ago by harmongreg
$CPHD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/2tEy
about 74 days ago by MarketBrief
about 74 days ago by MarketBrief
$CPHD great looking cht pos mention in ibd not sure why its down today?
about 74 days ago by RayGilliam
about 74 days ago by RayGilliam
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| CPHC | 12.98 | -0.01 | -0.08% | 53.21M |
| CPGI | 0.6344 | -0.08 | -11.79% | 24.61M |
| CPF | 12.92 | +0.04 | +0.31% | 539.41M |
| CPE | 4.54 | -0.08 | -1.73% | 178.92M |
| CPB | 32.58 | +0.02 | +0.06% | 10.31B |
| CPA | 83.85 | +0.62 | +0.74% | 3.713B |
| CLI | 27.14 | -0.22 | -0.80% | 2.383B |
| CLGX | 17.50 | +0.26 | +1.51% | 1.869B |
| CLFD | 4.30 | +0.11 | +2.63% | 52.93M |
